Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
3,36 USD | -5,88% | -3,72% | -12,50% |
Omzet 2024 * | - | Omzet 2025 * | - | Marktkapitalisatie | 202 mln. 187 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -68 mln. -63,14 mln. | Nettowinst (verlies) 2025 * | -93 mln. -86,36 mln. | EV/omzet 2024 * | - |
Nettoliquiditeiten 2024 * | 121 mln. 112 mln. | Nettoliquiditeiten 2025 * | 258 mln. 239 mln. | EV/omzet 2025 * | - |
K/w-verhouding 2024 * |
-2,75
x | K/w-verhouding 2025 * |
-2,12
x | Werknemers | 52 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 88,76% |
Recentste transcriptie over Acumen Pharmaceuticals, Inc.
1 dag | -5,88% | ||
1 week | -3,72% | ||
Lopende maand | +4,35% | ||
1 maand | -9,43% | ||
3 maanden | +3,70% | ||
6 maanden | +76,84% | ||
Lopend jaar | -12,50% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Daniel O'Connell
CEO | Chief Executive Officer | 54 | 01-04-06 |
Jim Doherty
PSD | President | 56 | 01/02 |
Matthew Zuga
DFI | Director of Finance/CFO | 58 | 01-05-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Daniel O'Connell
CEO | Chief Executive Officer | 54 | 01-04-06 |
Director/Board Member | 55 | 01-04-22 | |
Jeffrey Ives
BRD | Director/Board Member | 72 | 01-05-14 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.03% | 0 M€ | 0,00% | - | |
0.01% | 0 M€ | 0,00% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
10-05-24 | 3,36 | -5,88% | 123 504 |
09-05-24 | 3,57 | +5,00% | 173 292 |
08-05-24 | 3,4 | +1,19% | 149 900 |
07-05-24 | 3,36 | -5,62% | 140 393 |
06-05-24 | 3,56 | +2,01% | 177 331 |
uitgestelde koers Nasdaq, 10 mei 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-12,50% | 202 mln. | |
+17,96% | 44,96 mld. | |
+48,77% | 41,85 mld. | |
+1,17% | 42,65 mld. | |
-4,27% | 29,04 mld. | |
+11,42% | 26,08 mld. | |
-21,39% | 19,03 mld. | |
+4,86% | 12,75 mld. | |
+27,29% | 12,06 mld. | |
-3,50% | 11,75 mld. |